Storage time of platelet components and adverse reactions
| Days . | No adverse reaction (n = 2710)* . | Serious adverse reaction (n = 140)† . | ||
|---|---|---|---|---|
| SDA PCs‡ . | Pooled PCs§ . | SDA PCs‡ . | Pooled PCs§ . | |
| 1-2|| | 162 | 269 | 6 | 13 |
| 2-3 | 402 | 395 | 15 | 12 |
| 3-4 | 491 | 279 | 25 | 20 |
| 4-5 | 377 | 335 | 29 | 20 |
| Total (n = 2850) | 1432 | 1278 | 75 | 65 |
| Days . | No adverse reaction (n = 2710)* . | Serious adverse reaction (n = 140)† . | ||
|---|---|---|---|---|
| SDA PCs‡ . | Pooled PCs§ . | SDA PCs‡ . | Pooled PCs§ . | |
| 1-2|| | 162 | 269 | 6 | 13 |
| 2-3 | 402 | 395 | 15 | 12 |
| 3-4 | 491 | 279 | 25 | 20 |
| 4-5 | 377 | 335 | 29 | 20 |
| Total (n = 2850) | 1432 | 1278 | 75 | 65 |
No adverse reaction reported.
Serious adverse reaction reported.
Single donor, apheresis platelet component.
Whole blood buffy coat–derived blood component, pools of 5 ABO-RH:1 matched units, constituting 1 pooled platelet component.
Indicates that more than 24 hours have elapsed since the computer integrated timeframe of blood donation and less than 48 hours (maximum, 47 hours).